维普中文期刊产品整合服务
25篇 您的检索式:作者名="Fingleton B M"
    题名 作者 年代 出处 被引量
1Matrix meta-lloproteinase in hibitors and cancer:trials and tribulations显示文摘COUSSENS LM FINGLETON B MATRISIAN LM 2002Science2002,295,5564:1
2Matrix metalloproteinases: biologic activity and clinical inlplications显示文摘Nelson B A R Fingleton B F Rothenberg M L 2000J Clin Oncology2000,,:1
3Matrix metalloproteinases biologic activity and clinical inplications显示文摘Nelson B A R Fingleton B F Rothenberg M L 2000J Clin Oncology2000,50,6:1
4Matrix metalloproteinase biologic activity and clinical implications 显示文摘NELSON A R FINGLETON B ROTHENBERG M L 2000J Clin Oncol2000,18,5:1
5Matrix metalloproteinase inhibitors and cancer: trials nad tribulations 显示文摘Coussens L M Fingleton B Matrisian L M 2002Science2002,295,5564:1
6Matrix metalloproteinases biologic activity and clinical inplications显示文摘Nelson B A R Fingleton B F Rothenberg M L 2000Clin Oncology2000,50,:1
7Matrix metalloproteinases: biologic activity and clinical implications显示文摘Nelson A R Fingleton B Rothenberg M L 2000J Clin Oncol2000,18,5:1
82012, Evaluating China's road to prosperity:a new economic geography approach 显示文摘ROBERTS M DEICHMANN U FINGLETON B 2012Regional Science and Urban Economics2012,,4:1
9Matrixmetalloproteinase inhibitors and cancer: trials andtribulations 显示文摘Coussens L M Fingleton B Matrisian L M 2002Science2002,295,5564:1
10The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis显示文摘Powell WC Fingleton B Wilson CL Boothby M Matrisian LM 0,,:1
11Matrix metalloproteinase biologic activity and clinical implications 显示文摘NELSON A R FINGLETON B ROTHENBERG M L 2000J Clin Oncol2000,18,1:1
12Matrix metalloproteinase:biologic activity and clinical implications显示文摘Nelson AR Fingleton B Rothenberg M 2001J Clin Oncol2001,18,5:1
13Analysis of Host- and Tumor-Derived Proteinases Using a Custom Dual Species Microarray Reveals a Protective Role for Stromal Matrix Metalloproteinase-12 in Non-Small Cell Lung Cancer 显示文摘Acuff H B Sinnamon M Fingleton B 2006Cancer Res2006,66,16:1
14Matrix metalloproteinases:biologic activity and clinical implications显示文摘Nelson A R Fingleton B Rothenberg M L 2000Joumal of Clinical Oncology2000,18,5:1
15The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors 显示文摘Crawford H C Fingleton B M Rudolph-Owen L A 1999Oncogene1999,18,18:1
16Ma-trix metalloproteinases : biologic activity and clinical implications显示文摘NELSON A R FINGLETON B ROTHENBERG M L 2000J Clin Oncol2000,18,5:1
17Matrix Metalloproteinase Inhibitors and Cancer: Trials and Tribula tions 显示文摘Conssens L M Fingleton B Matrisian L M 2002Science2002,295,5564:1
18Matrix metalloproteinase inhibitors and cancer: trials and tribulations显示文摘COUSSENS L M FINGLETON B MATRISIAN L M 2002Science2002,295,:1
19Matrix metalloproteinases:biologic activity and clinical implications 显示文摘Nelson A R Fingleton B Rothenberg M L 2000J Clin Oncol2000,18,5:1
20Matrix metalloproteinases:biologic activity and clinical implications显示文摘Nelson B A R Fingleton B F Rothenberg M L 2000J Clin Oncology2000,18,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费